Cervical cancer is one of the most common cancers in the world both in terms of incidence
and mortality, more so important in low-and middle-income countries. Surgery and …

Introduction: Worldwide, most cervical cancer (CC) patients require the use of drug therapy
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …

Vascular endothelial growth factor (VEGF) has emerged as a therapeutic target in several
malignancies, including cervical cancer. Chemotherapy doublets combined with the fully …

Cervical cancer remains unique among solid tumor malignancies. Persistent infection with
oncogenic subtypes of the human papillomavirus (HPV) results in carcinogenesis …

The addition of bevacizumab to established therapies for metastatic and locally advanced
cervical cancer is an area of evolving research and a potential strategy toward improving …

Worldwide, cervical cancer is one of the most common cancers in women [1]. About 450,000
women are diagnosed with cervical cancer each year around the world, and another …

Introduction: Cervical cancer is still a major cause of morbidity and mortality in women. Early
stages and locally advanced cervical cancer are currently treated respectively with surgery …

Patients with advanced stage or recurrent cervical cancer represent a population with limited
chemotherapeutic options. More specifically, patients with recurrent disease have a poor …

Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Introduction From a therapeutic standpoint, invasive cervical cancer can be designated as
early, locally advanced, and advanced stages. Systemic treatment remains the primary …